首页分享宠物诊断服务市场

宠物诊断服务市场

来源：萌宠菠菠乐园时间：2026-03-12 00:09

市场调查报告书

商品编码

1953743

Companion Animal Diagnostic Services Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Testing, By Type (Point-of-Care, Laboratory-based), By Animal Type, By Region & Competition, 2021-2031F

价格

全球伴侣动物诊断服务市场预计将从 2025 年的 29.4 亿美元成长到 2031 年的 44.9 亿美元，复合年增长率为 7.31%。

这些服务包括临床病理学、分子诊断和影像诊断，兽医利用这些服务诊断和治疗伴侣动物，包括犬、猫和马。推动这些服务发展的主要因素是老龄化动物群体中慢性病发病率的上升，以及「宠物人性化」的趋势——即饲主将宠物的医疗保健置于与人类同等的地位。此外，通用感染疾病的日益威胁也需要严格的监测和检测，这使得这些诊断工具在现代兽医学中显得特别重要。

市场概览预测期 2027-2031 市场规模：2025年 29.4亿美元市场规模：2031年 44.9亿美元复合年增长率：2026-2031年 7.31% 成长最快的细分市场狗最大的市场北美洲

儘管存在这些成长要素，但市场仍面临兽医和病理学家严重短缺的问题，这限制了服务能力并增加了营运成本。这种短缺可能会延误诊断结果的解读，并限制高需求地区服务提供者的收入成长。然而，市场需求依然强劲。根据美国宠物用品协会 (APPA) 预测，到 2024 年，该行业预计将保持强劲增长势头，届时美国兽医护理支出和产品销售额总合将达到 398 亿美元。

市场驱动因素

宠物人性化的趋势是推动诊断服务需求成长的主要因素。随着饲主越来越将宠物视为家庭成员，这种文化转变直接促进了临床服务的使用，从而增加了兽医在疾病早期检测、健康检查和高级病理检测方面的医疗费用支出，以确保动物健康。欧洲宠物食品协会 (FEDIAF) 的《2024 年事实与数据》报告也印证了这项高需求。该报告指出，截至 2024 年 6 月，欧盟约有 9,100 万户家庭将至少拥有一隻宠物，这将对兽医基础设施产生巨大需求，并确保诊断服务提供者拥有稳定的病例来源。

同时，宠物保险覆盖范围的扩大正在消除以往阻碍宠物获得全面诊断服务的经济障碍。保险选择的增加使得饲主无需即时支付自付费用即可核准核磁共振成像（MRI）和分子检测等昂贵的检查，从而促进了从症状治疗向循证医学的转变。北美宠物健康保险协会（NAPHIA）发布的《2024年产业趋势报告》也反映了这一趋势，该报告指出，截至2024年5月，北美地区的保费总额达到了创纪录的42.7亿美元。这项影响在公司层级也显而易见，IDEXX Laboratories报告称，其伴侣动物部门2024年第三季的全球诊断经常性收入增加了7%。

市场挑战

合格兽医和病理学家的短缺造成了严重的营运瓶颈，并成为市场扩张的一大障碍。当诊所和实验室缺乏足够的人员来执行操作和解读复杂的影像诊断和分子检测结果时，重要检测结果的周转时间会显着延长。这些延误迫使兽医推迟治疗决策，从而减少了他们能够有效治疗的病例数。因此，服务提供者无法充分利用检测需求的激增，从而有效地限制了潜在的收入成长。

此外，人才短缺造成了严重的财务压力，降低了利润率，并限制了对拓展服务的投资。为了吸引有限的人才，兽医诊所被迫增加营运成本，通常采取提高工资和聘用高薪临时工的方式。英国兽医协会 (BVA) 2024 年的调查凸显了这个问题，调查显示，平均每家诊所有 2.1 个全职兽医职位空缺，约占总员工人数的 23%。如此高的空缺率直接限制了诊所处理诊断样本的能力，抑制了整个市场的上升趋势。

市场趋势

人工智慧 (AI) 正日益融入兽医实践，以提高预测诊断的准确性并缓解人手不足的压力。能够自动分析复杂影像的 AI 技术可在诊断放射学中提供即时第二意见，从而加快诊断流程并消除操作瓶颈。这种应用正在加速发展；根据美国兽医协会 (AVMA) 2025 年 2 月发布的报告《兽医专业人员对人工智慧的理解、乐观态度和应用：2024 年调查》，39.2% 的受访者已在其专业实践中使用 AI 工具，以帮助优化病例管理并促进快速治疗性介入。

同时，非侵入性液态生物检体技术的兴起正在革新肿瘤学，只需简单的抽血即可进行癌症筛检，而无需进行侵入性的组织取样。这项创新满足了人们对便利的早期监测的需求，尤其适用于老年宠物，因为传统切片检查的风险对它们而言难以接受。 VolitionRx Limited 于 2025 年 3 月发布的《2024 年全年财务报告》证实了这项技术的商业性扩充性，该报告显示，2024 年 Nu.Q Vet 癌症检测的销量约为 12 万份。这一增长预示着人们正朝着预防性健康监测的方向转变，从而能够在临床症状恶化之前治疗性介入。

第一章概述第二章调查方法第三章执行摘要第四章：客户评价第五章：全球宠物诊断服务市场展望市场规模及预测按金额市占率及预测按检测类型（临床化学、微生物学、寄生虫学、组织病理学、细胞病理学、血液学、免疫学/血清学、影像诊断、分子诊断、其他）依类型（照护现场(POC)、检查室检测）依动物种类（狗、猫、马、其他）按地区按公司（2025 年）市场地图 6. 北美宠物诊断服务市场展望市场规模及预测市占率及预测北美洲：国家分析我们加拿大墨西哥 7. 欧洲宠物诊断服务市场展望市场规模及预测市占率及预测欧洲：国家分析德国法国英国义大利西班牙 8. 亚太地区宠物诊断服务市场展望市场规模及预测市占率及预测亚太地区：国家分析中国印度日本韩国澳洲 9. 中东和非洲宠物诊断服务市场展望市场规模及预测市占率及预测中东和非洲：国家分析沙乌地阿拉伯阿拉伯聯合大公国南非第十章：南美洲宠物诊断服务市场展望市场规模及预测市占率及预测南美洲：国家分析巴西哥伦比亚阿根廷第十一章市场动态司机任务第十二章市场趋势与发展併购产品发布最新进展第十三章全球宠物诊断服务市场：SWOT分析第十四章：波特五力分析产业竞争新进入者的可能性供应商电力顾客权力替代品的威胁第十五章竞争格局 IDEXX Laboratories, Inc. Zoetis Inc. Virbac Heska Corporation Neogen Corporation Bio-Rad Laboratories, Inc. INDICAL Bioscience GmbH Agrolabo SpA ID.vet bioMerieux SA 第十六章策略建议第十七章：关于研究公司及免责声明

Product Code: 23714

The Global Companion Animal Diagnostic Services Market is projected to expand from USD 2.94 billion in 2025 to USD 4.49 billion by 2031, registering a CAGR of 7.31%. These services, which include clinical pathology, molecular diagnostics, and imaging, are utilized by veterinarians to diagnose and treat pets such as dogs, cats, and equines. Growth is largely fueled by the rising prevalence of chronic conditions in aging animal populations and the trend of pet humanization, where owners prioritize human-grade healthcare. Additionally, the increasing threat of zoonotic diseases necessitates strict surveillance and testing, further cementing the importance of these diagnostic tools in modern veterinary practice.

Market Overview Forecast Period2027-2031 Market Size 2025USD 2.94 Billion Market Size 2031USD 4.49 Billion CAGR 2026-20317.31% Fastest Growing SegmentDogs Largest MarketNorth America

Despite these growth drivers, the market faces hurdles due to a severe global shortage of qualified veterinary professionals and pathologists, which limits service capacity and raises operational costs. This labor gap slows down diagnostic interpretation, potentially capping revenue generation for providers in high-demand areas. However, market demand remains strong; according to the American Pet Products Association, the sector saw robust activity in 2024, with spending on veterinary care and product sales reaching $39.8 billion in the United States.

Market Driver

The trend of pet humanization is a major catalyst for diagnostic service demand, as owners increasingly view their companion animals as integral family members. This cultural shift leads to a greater willingness to incur veterinary expenses for early disease detection, wellness screenings, and advanced pathology, directly increasing the utilization of clinical services to ensure animal health. Supporting this high demand, data from the FEDIAF EuropeanPetFood 'Facts & Figures 2024' report indicates that approximately 91 million European Union households owned at least one pet as of June 2024, creating a substantial need for veterinary care infrastructure and ensuring a steady stream of cases for diagnostic providers.

Concurrently, the expansion of pet insurance coverage is eliminating financial obstacles that historically restricted access to comprehensive diagnostic procedures. Broader insurance options encourage owners to authorize costly tests like MRI scans and molecular assays without the burden of immediate out-of-pocket expenses, fostering a shift from symptomatic treatment to evidence-based medicine. This trend is reflected in the North American Pet Health Insurance Association's 'State of the Industry Report 2024,' which noted a historic high of $4.27 billion in total premiums in North America by May 2024. The impact is visible corporately, with Idexx Laboratories reporting a 7 percent increase in global Companion Animal Group diagnostic recurring revenues in the third quarter of 2024.

Market Challenge

The scarcity of qualified veterinary professionals and pathologists presents a critical obstacle to market expansion by causing severe operational bottlenecks. When clinics and laboratories lack sufficient staff to perform procedures or interpret complex diagnostic images and molecular tests, turnaround times for critical results increase substantially. These delays force veterinarians to defer treatment decisions and reduce the volume of cases that can be managed effectively, preventing service providers from fully capitalizing on the surging demand for tests and effectively capping potential revenue growth.

Furthermore, this labor shortage creates intense financial pressure that erodes profit margins and restricts investment in service expansion. Veterinary practices are compelled to increase overhead costs to compete for limited talent, often resorting to higher wages or expensive temporary staffing. A 2024 survey by the British Veterinary Association highlighted this issue, revealing that clinical practices averaged 2.1 unfilled full-time equivalent veterinary roles, representing approximately 23% of their total workforce capacity. Such high vacancy rates directly constrain the physical ability of facilities to process diagnostic samples, thereby stalling the market's overall upward trajectory.

Market Trends

Artificial Intelligence (AI) is increasingly being integrated into veterinary workflows to enhance predictive diagnostics and alleviate the strain caused by workforce shortages. By automating complex image analysis, AI allows for immediate second opinions in radiology, thereby speeding up diagnostic processes and mitigating operational bottlenecks. This adoption is gaining momentum; the American Veterinary Medical Association's February 2025 report, 'Familiarity with artificial intelligence drives optimism and adoption among veterinary professionals: 2024 survey,' found that 39.2% of respondents are now utilizing AI tools for professional tasks, which helps optimize case management and facilitate faster treatment interventions.

In parallel, the rise of non-invasive liquid biopsy is revolutionizing oncology by permitting cancer screening through simple blood draws instead of invasive tissue sampling. This innovation addresses the need for accessible, early-stage monitoring, particularly for aging pets where traditional biopsy risks are prohibitive. The commercial scalability of this technology is evident in VolitionRx Limited's 'Full Fiscal Year 2024 Financial Results' from March 2025, which reported sales of approximately 120,000 Nu.Q Vet Cancer Tests in 2024. This growth signifies a broader pivot toward proactive wellness monitoring, allowing for therapeutic intervention before clinical symptoms escalate.

Key Market Players IDEXX Laboratories, Inc. Zoetis Inc. Virbac Heska Corporation Neogen Corporation Bio-Rad Laboratories, Inc. INDICAL Bioscience GmbH Agrolabo SpA ID.vet bioMerieux S.A.

Report Scope

In this report, the Global Companion Animal Diagnostic Services Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Companion Animal Diagnostic Services Market, By Testing Clinical Chemistry Microbiology Parasitology Histopathology Cytopathology Hematology Immunology & Serology Imaging Molecular Diagnostics Others Companion Animal Diagnostic Services Market, By Type Point-of-Care (POC) Laboratory-based Companion Animal Diagnostic Services Market, By Animal Type Dogs Cats Horses Others Companion Animal Diagnostic Services Market, By Region North America United States Canada Mexico Europe France United Kingdom Italy Germany Spain Asia Pacific China India Japan Australia South Korea South America Brazil Argentina Colombia Middle East & Africa South Africa Saudi Arabia UAE Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Companion Animal Diagnostic Services Market.

Available Customizations:

Global Companion Animal Diagnostic Services Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information Detailed analysis and profiling of additional market players (up to five).

1. Product Overview 1.1. Market Definition 1.2. Scope of the Market 1.2.1. Markets Covered 1.2.2. Years Considered for Study 1.2.3. Key Market Segmentations 2. Research Methodology 2.1. Objective of the Study 2.2. Baseline Methodology 2.3. Key Industry Partners 2.4. Major Association and Secondary Sources 2.5. Forecasting Methodology 2.6. Data Triangulation & Validation 2.7. Assumptions and Limitations 3. Executive Summary 3.1. Overview of the Market 3.2. Overview of Key Market Segmentations 3.3. Overview of Key Market Players 3.4. Overview of Key Regions/Countries 3.5. Overview of Market Drivers, Challenges, Trends 4. Voice of Customer 5. Global Companion Animal Diagnostic Services Market Outlook 5.1. Market Size & Forecast 5.1.1. By Value 5.2. Market Share & Forecast 5.2.1. By Testing (Clinical Chemistry, Microbiology, Parasitology, Histopathology, Cytopathology, Hematology, Immunology & Serology, Imaging, Molecular Diagnostics, Others) 5.2.2. By Type (Point-of-Care (POC), Laboratory-based) 5.2.3. By Animal Type (Dogs, Cats, Horses, Others) 5.2.4. By Region 5.2.5. By Company (2025) 5.3. Market Map 6. North America Companion Animal Diagnostic Services Market Outlook 6.1. Market Size & Forecast 6.1.1. By Value 6.2. Market Share & Forecast 6.2.1. By Testing 6.2.2. By Type 6.2.3. By Animal Type 6.2.4. By Country 6.3. North America: Country Analysis 6.3.1. United States Companion Animal Diagnostic Services Market Outlook 6.3.1.1. Market Size & Forecast 6.3.1.1.1. By Value 6.3.1.2. Market Share & Forecast 6.3.1.2.1. By Testing 6.3.1.2.2. By Type 6.3.1.2.3. By Animal Type 6.3.2. Canada Companion Animal Diagnostic Services Market Outlook 6.3.2.1. Market Size & Forecast 6.3.2.1.1. By Value 6.3.2.2. Market Share & Forecast 6.3.2.2.1. By Testing 6.3.2.2.2. By Type 6.3.2.2.3. By Animal Type 6.3.3. Mexico Companion Animal Diagnostic Services Market Outlook 6.3.3.1. Market Size & Forecast 6.3.3.1.1. By Value 6.3.3.2. Market Share & Forecast 6.3.3.2.1. By Testing 6.3.3.2.2. By Type 6.3.3.2.3. By Animal Type 7. Europe Companion Animal Diagnostic Services Market Outlook 7.1. Market Size & Forecast 7.1.1. By Value 7.2. Market Share & Forecast 7.2.1. By Testing 7.2.2. By Type 7.2.3. By Animal Type 7.2.4. By Country 7.3. Europe: Country Analysis 7.3.1. Germany Companion Animal Diagnostic Services Market Outlook 7.3.1.1. Market Size & Forecast 7.3.1.1.1. By Value 7.3.1.2. Market Share & Forecast 7.3.1.2.1. By Testing 7.3.1.2.2. By Type 7.3.1.2.3. By Animal Type 7.3.2. France Companion Animal Diagnostic Services Market Outlook 7.3.2.1. Market Size & Forecast 7.3.2.1.1. By Value 7.3.2.2. Market Share & Forecast 7.3.2.2.1. By Testing 7.3.2.2.2. By Type 7.3.2.2.3. By Animal Type 7.3.3. United Kingdom Companion Animal Diagnostic Services Market Outlook 7.3.3.1. Market Size & Forecast 7.3.3.1.1. By Value 7.3.3.2. Market Share & Forecast 7.3.3.2.1. By Testing 7.3.3.2.2. By Type 7.3.3.2.3. By Animal Type 7.3.4. Italy Companion Animal Diagnostic Services Market Outlook 7.3.4.1. Market Size & Forecast 7.3.4.1.1. By Value 7.3.4.2. Market Share & Forecast 7.3.4.2.1. By Testing 7.3.4.2.2. By Type 7.3.4.2.3. By Animal Type 7.3.5. Spain Companion Animal Diagnostic Services Market Outlook 7.3.5.1. Market Size & Forecast 7.3.5.1.1. By Value 7.3.5.2. Market Share & Forecast 7.3.5.2.1. By Testing 7.3.5.2.2. By Type 7.3.5.2.3. By Animal Type 8. Asia Pacific Companion Animal Diagnostic Services Market Outlook 8.1. Market Size & Forecast 8.1.1. By Value 8.2. Market Share & Forecast 8.2.1. By Testing 8.2.2. By Type 8.2.3. By Animal Type 8.2.4. By Country 8.3. Asia Pacific: Country Analysis 8.3.1. China Companion Animal Diagnostic Services Market Outlook 8.3.1.1. Market Size & Forecast 8.3.1.1.1. By Value 8.3.1.2. Market Share & Forecast 8.3.1.2.1. By Testing 8.3.1.2.2. By Type 8.3.1.2.3. By Animal Type 8.3.2. India Companion Animal Diagnostic Services Market Outlook 8.3.2.1. Market Size & Forecast 8.3.2.1.1. By Value 8.3.2.2. Market Share & Forecast 8.3.2.2.1. By Testing 8.3.2.2.2. By Type 8.3.2.2.3. By Animal Type 8.3.3. Japan Companion Animal Diagnostic Services Market Outlook 8.3.3.1. Market Size & Forecast 8.3.3.1.1. By Value 8.3.3.2. Market Share & Forecast 8.3.3.2.1. By Testing 8.3.3.2.2. By Type 8.3.3.2.3. By Animal Type 8.3.4. South Korea Companion Animal Diagnostic Services Market Outlook 8.3.4.1. Market Size & Forecast 8.3.4.1.1. By Value 8.3.4.2. Market Share & Forecast 8.3.4.2.1. By Testing 8.3.4.2.2. By Type 8.3.4.2.3. By Animal Type 8.3.5. Australia Companion Animal Diagnostic Services Market Outlook 8.3.5.1. Market Size & Forecast 8.3.5.1.1. By Value 8.3.5.2. Market Share & Forecast 8.3.5.2.1. By Testing 8.3.5.2.2. By Type 8.3.5.2.3. By Animal Type 9. Middle East & Africa Companion Animal Diagnostic Services Market Outlook 9.1. Market Size & Forecast 9.1.1. By Value 9.2. Market Share & Forecast 9.2.1. By Testing 9.2.2. By Type 9.2.3. By Animal Type 9.2.4. By Country 9.3. Middle East & Africa: Country Analysis 9.3.1. Saudi Arabia Companion Animal Diagnostic Services Market Outlook 9.3.1.1. Market Size & Forecast 9.3.1.1.1. By Value 9.3.1.2. Market Share & Forecast 9.3.1.2.1. By Testing 9.3.1.2.2. By Type 9.3.1.2.3. By Animal Type 9.3.2. UAE Companion Animal Diagnostic Services Market Outlook 9.3.2.1. Market Size & Forecast 9.3.2.1.1. By Value 9.3.2.2. Market Share & Forecast 9.3.2.2.1. By Testing 9.3.2.2.2. By Type 9.3.2.2.3. By Animal Type 9.3.3. South Africa Companion Animal Diagnostic Services Market Outlook 9.3.3.1. Market Size & Forecast 9.3.3.1.1. By Value 9.3.3.2. Market Share & Forecast 9.3.3.2.1. By Testing 9.3.3.2.2. By Type 9.3.3.2.3. By Animal Type 10. South America Companion Animal Diagnostic Services Market Outlook 10.1. Market Size & Forecast 10.1.1. By Value 10.2. Market Share & Forecast 10.2.1. By Testing 10.2.2. By Type 10.2.3. By Animal Type 10.2.4. By Country 10.3. South America: Country Analysis 10.3.1. Brazil Companion Animal Diagnostic Services Market Outlook 10.3.1.1. Market Size & Forecast 10.3.1.1.1. By Value 10.3.1.2. Market Share & Forecast 10.3.1.2.1. By Testing 10.3.1.2.2. By Type 10.3.1.2.3. By Animal Type 10.3.2. Colombia Companion Animal Diagnostic Services Market Outlook 10.3.2.1. Market Size & Forecast 10.3.2.1.1. By Value 10.3.2.2. Market Share & Forecast 10.3.2.2.1. By Testing 10.3.2.2.2. By Type 10.3.2.2.3. By Animal Type 10.3.3. Argentina Companion Animal Diagnostic Services Market Outlook 10.3.3.1. Market Size & Forecast 10.3.3.1.1. By Value 10.3.3.2. Market Share & Forecast 10.3.3.2.1. By Testing 10.3.3.2.2. By Type 10.3.3.2.3. By Animal Type 11. Market Dynamics 11.1. Drivers 11.2. Challenges 12. Market Trends & Developments 12.1. Merger & Acquisition (If Any) 12.2. Product Launches (If Any) 12.3. Recent Developments 13. Global Companion Animal Diagnostic Services Market: SWOT Analysis 14. Porter's Five Forces Analysis 14.1. Competition in the Industry 14.2. Potential of New Entrants 14.3. Power of Suppliers 14.4. Power of Customers 14.5. Threat of Substitute Products 15. Competitive Landscape 15.1. IDEXX Laboratories, Inc. 15.1.1. Business Overview 15.1.2. Products & Services 15.1.3. Recent Developments 15.1.4. Key Personnel 15.1.5. SWOT Analysis 15.2. Zoetis Inc. 15.3. Virbac 15.4. Heska Corporation 15.5. Neogen Corporation 15.6. Bio-Rad Laboratories, Inc. 15.7. INDICAL Bioscience GmbH 15.8. Agrolabo SpA 15.9. ID.vet 15.10. bioMerieux S.A. 16. Strategic Recommendations 17. About Us & Disclaimer